Abstract Background It has been shown that approximately half of survivors of childhood acute lymphoblastic leukemia (ALL) have symptomatic late effects (LE) that may be severe or life-threatening. The aim of our study was to assess the health status of childhood ALL survivors after over 10 years of follow-up and to assess its relationships with gene polymorphisms, numbers and types of LEs, as well as with intensity of chemotherapy and cranial radiotherapy (CRT). Methods We conducted a telephone survey in 125 ALL survivors (median time from completion of treatment was 12 years) and compared the results with those obtained in our previous study. Most of the patients were followed-up by local providers. Results The prevalence of LEs of approx...
Background Relapses occur in about 20% of children with acute lymphoblastic leukemia (ALL). Appro...
Recent progress in risk-adapted treatment for childhood acute lymphoblastic leukemia has secured 5-y...
Objectives Every day 43 children are newly diagnosed with cancer. Fortunately, almost 90% of these c...
Introduction More than 90% of patients diagnosed with childhood acute lymphoblastic leukaemia (ALL) ...
During the last few decades, pediatric acute lymphoblastic leukemia (ALL) cure rates have improved s...
BACKGROUND Treatment of patients with paediatric acute lymphoblastic leukaemia has evolved such t...
BackgroundKnowledge regarding late effects (medical conditions and subsequent neoplasms) in survivor...
Acute lymphoblastic leukemia (ALL) survivors are the largest group of childhood cancer survivors; ho...
PURPOSE: Risk-stratified therapy, which modifies treatment on the basis of clinical and biologic fea...
BackgroundA substantial number of survivors of childhood acute lymphoblastic leukemia suffer from tr...
In Australia, up to 80% of individuals diagnosed with childhood cancer are now expected to survive f...
BACKGROUND: Prior studies have identified that survivors of childhood acute lymphoblastic leukemia (...
Objective: Investigate all-cause and cause-specific late mortality after childhood acute lymphoblast...
Childhood acute lymphoblastic leukemia (ALL) survivors are at higher risk of developing many late ef...
Simple Summary Long-term quality of life and its potential risk factors in childhood acute lymphobla...
Background Relapses occur in about 20% of children with acute lymphoblastic leukemia (ALL). Appro...
Recent progress in risk-adapted treatment for childhood acute lymphoblastic leukemia has secured 5-y...
Objectives Every day 43 children are newly diagnosed with cancer. Fortunately, almost 90% of these c...
Introduction More than 90% of patients diagnosed with childhood acute lymphoblastic leukaemia (ALL) ...
During the last few decades, pediatric acute lymphoblastic leukemia (ALL) cure rates have improved s...
BACKGROUND Treatment of patients with paediatric acute lymphoblastic leukaemia has evolved such t...
BackgroundKnowledge regarding late effects (medical conditions and subsequent neoplasms) in survivor...
Acute lymphoblastic leukemia (ALL) survivors are the largest group of childhood cancer survivors; ho...
PURPOSE: Risk-stratified therapy, which modifies treatment on the basis of clinical and biologic fea...
BackgroundA substantial number of survivors of childhood acute lymphoblastic leukemia suffer from tr...
In Australia, up to 80% of individuals diagnosed with childhood cancer are now expected to survive f...
BACKGROUND: Prior studies have identified that survivors of childhood acute lymphoblastic leukemia (...
Objective: Investigate all-cause and cause-specific late mortality after childhood acute lymphoblast...
Childhood acute lymphoblastic leukemia (ALL) survivors are at higher risk of developing many late ef...
Simple Summary Long-term quality of life and its potential risk factors in childhood acute lymphobla...
Background Relapses occur in about 20% of children with acute lymphoblastic leukemia (ALL). Appro...
Recent progress in risk-adapted treatment for childhood acute lymphoblastic leukemia has secured 5-y...
Objectives Every day 43 children are newly diagnosed with cancer. Fortunately, almost 90% of these c...